Common Contracts

LUCID DIAGNOSTICS INC. [NUMBER OF SHARES] Shares of Common Stock (par value $0.001 per share) Underwriting Agreement

Underwriting Agreement • October 8th, 2021 • Lucid Diagnostics Inc. • Surgical & medical instruments & apparatus • New York

• Contract Type
  Underwriting Agreement
• Filed
  October 8th, 2021
• Company
  Lucid Diagnostics Inc.
• Industry
  Surgical & medical instruments & apparatus
• Jurisdiction
  New York

Lucid Diagnostics Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of [●] shares of its common stock, par value $0.001 per share (the “Shares”). The [●] Shares to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional [●] Shares. The additional [●] Shares to be sold by the Company pursuant to such option are collectively called the “Option Shares.” The Firm Shares and, if and to the extent such option is exercised, the Option Shares, are collectively called the “Offered Shares.” Cantor Fitzgerald & Co. (“Cantor”) and Canaccord Genuity LLC (“Canaccord”) have agreed to act as representatives of the several Underwriters (in such capacity, the “Representatives”) in connection with the offering and sale of the Offered Shares.

9,047,741 Shares of Common Stock ABM Industries Incorporated UNDERWRITING AGREEMENT

Underwriting Agreement • March 19th, 2018 • Abm Industries Inc /De/ • Services-to dwellings & other buildings • New York

• Contract Type
  Underwriting Agreement
• Filed
  March 19th, 2018
• Company
  Abm Industries Inc /De/
• Industry
  Services-to dwellings & other buildings
• Jurisdiction
  New York

Introductory. Certain stockholders of ABM Industries Incorporated, a Delaware corporation (the “Company”), named in Schedule A (collectively, the “Selling Stockholders”) propose to sell to the several underwriters named in Schedule B (the “Underwriters”) an aggregate of 9,047,741 shares of the Company’s common stock, par value $0.01 per share (the “Shares”). The 9,047,741 Shares to be sold by the Selling Stockholders are collectively called the “Offered Shares.” Goldman Sachs & Co. LLC (“GS”) and UBS Securities LLC (“UBS”) have agreed to act as representatives of the several Underwriters (in such capacity, the “Representatives”) in connection with the offering and sale of the Offered Shares. To the extent there are no additional underwriters listed on Schedule B, the term “Representatives” as used herein shall mean you, as Underwriters, and the term “Underwriters” shall mean either the singular or the plural, as the context requires.